secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECIGEN, INC. (PGEN)
CIK:        0001356090
Form:       8-K
Filed at:   2022-08-09T23:59:59+00:00
Accession:  0000950103-22-013822
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precigen enters $100M ATM equity offering with Cantor Fitzgerald
----------------------------------------------------------------

- Up to $100M of common stock may be sold at-the-market through Cantor Fitzgerald as agent.
- Commission of 3.0% of gross sales price payable to Cantor Fitzgerald.
- Proceeds to fund clinical/preclinical development and for working capital and general corporate purposes.
- Company has no obligation to sell any shares; may suspend or terminate at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356090/000095010322013822/0000950103-22-013822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356090/000095010322013822/dp178412_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-22-013822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer